Next Article in Journal
A Real-World Experience on the Efficacy of First-Line Treatment with Immune-Checkpoint Inhibitors in Non-Small-Cell Lung Cancer Patients with PD-L1 Expression ≥50%: The Role of KRAS Mutations
Previous Article in Journal
MicroRNAs Modulating Cancer Immunotherapy Mechanisms and Therapeutic Synergies
 
 
Article

Article Versions Notes

Cancers 2025, 17(24), 3979; https://doi.org/10.3390/cancers17243979
Action Date Notes Link
article html file updated 13 December 2025 09:03 CET Original file https://www.mdpi.com/2072-6694/17/24/3979/html
article pdf uploaded. 13 December 2025 09:01 CET Version of Record https://www.mdpi.com/2072-6694/17/24/3979/pdf
article xml uploaded. 13 December 2025 09:01 CET Update https://www.mdpi.com/2072-6694/17/24/3979/xml
article xml file uploaded 13 December 2025 09:01 CET Original file -
Back to TopTop